Ophthalmology And Therapy

雜志介紹

Ophthalmology And Therapy雜志介紹

《Ophthalmology And Therapy》是一本以English為主的開放獲取國際優秀期刊，中文名稱眼科和治療，本刊主要出版、報道醫學-OPHTHALMOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.6，最新CiteScore 指數為4.2。

本刊近期中國學者發表的論文主要有：

• Nonsurgical Management of Severe Viral Keratitis with Hypopyon and Retrocorneal Plaques: A Case Series

  Author: Yang, Zhen; Yu, Shuo; Zhang, Chun; Agrawal, Rupesh; Feng, Yun

• The Double-Deck Viscoelastic Technique: a Novel Surgical Technique to Protect the Corneal Endothelium in Penetrating Keratoplasty of Aphakic Silicone Oil-Dependent Eyes after Severe Ocular Injury

  Author: Cen, Yujie; Zhang, Mingzhou; Lu, Yao; Feng, Yun

• Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy

  Author: Zhou, Huiying; Zhao, Xinyu; Wang, Shuran; Chen, Youxin

• Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study

  Author: Li, Yu; Qi, Yue; Sun, Mingshen; Zhai, Changbin; Wei, Wenbin; Zhang, Fengju

英文介紹

Ophthalmology And Therapy雜志英文介紹

Ophthalmology And Therapy is an open access, peer-reviewed (single-blind), fast-publishing international journal. The scope of the journal is broad and will consider all scientifically sound research, from preclinical, clinical (all stages), observational, real-world and health outcome studies, around the use of ophthalmic therapies, devices and surgical techniques.

The journal is of interest to a broad range of pharmaceutical and healthcare professionals and publishes short newsletters such as original studies, reviews, case reports/series, trial protocols, and reviews and editorials. Ophthalmology and treatment will consider all scientifically sound studies, whether positive, confirmed or negative data. Submissions are welcome regardless of whether they reach an international and/or country-specific audience, which is crucial when researchers are trying to target more specific patient groups. This inclusive approach allows the journal to assist in disseminating high-quality research, which may be considered of insufficient interest by other journals.